Traders Are Watching: Protalix BioTherapeutics, Inc. (NYSEMKT:PLX), EnLink Midstream, LLC (NYSE:ENLC), Skyline Corp. (NYSEMKT:SKY), Adamas Pharmaceuticals, Inc.

Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) announced that the Company will participate in the 12th Annual WORLDSymposiumTM 2016 February 29 – March 4, 2016
Manchester Grand Hyatt, San Diego, CA.

Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) belongs to Healthcare sector. Its weekly performance is 5.38%. On last trading day company shares ended up at $0.84. Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) distance from 50-day simple moving average (SMA50) is -4.04%.

On 16 February, EnLink Midstream, LLC (NYSE:ENLC) reported a net loss of $723.4 million for the fourth quarter of 2015 compared with net income of $75.6 million in the fourth quarter of 2014. The net loss in the fourth quarter of 2015 was primarily due to the previously mentioned non-cash expense of $764.2 million related to goodwill and asset impairments. The General Partner’s cash available for distribution was $47.8 million in the fourth quarter of 2015 compared with cash available for distribution of $66.3 million in the fourth quarter of 2014.

EnLink Midstream, LLC (NYSE:ENLC) shares advanced 10.36% in last trading session and ended the day at $7.99. ENLC Gross Margin is 27.00% and its return on assets is -3.40%. EnLink Midstream, LLC (NYSE:ENLC) quarterly performance is -52.75%.

On 26 February, Skyline Corp. (NYSEMKT:SKY) shares remains unchanged and was closed at $3.97. SKY EPS growth in last 5 year was 32.10%. Skyline Corp. (NYSEMKT:SKY) year to date (YTD) performance is 11.65%.

On 23 February, Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) announced financial results for the fourth quarter and full year ended December 31, 2015. Adamas reported a net loss attributable to common stockholders of $51.8 million, or $2.86 per share, for the year ended December 31, 2015. In the prior year, the company reported net income attributable to common stockholders of $9.1 million, or $0.53 per diluted share, as a result of $55.0 million of development milestones from Forest Laboratories Holdings Limited (“Forest”) recorded as revenue during the year ended December 31, 2014.

Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) ended the last trading day at $13.20. Company weekly volatility is calculated as 7.89%. Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) showed a weekly performance of -11.59%.

ANSYS, Inc. (NASDAQ:ANSS) announced that its Annual Meeting of Stockholders will be held on Friday, May 20, 2016 at 11:30 a.m. (EDT) at 250 Technology Drive in Canonsburg, Pennsylvania.

Ansys, Inc. (NASDAQ:ANSS) shares decreased -0.19% in last trading session and ended the day at $84.06. ANSS Gross Margin is 84.10% and its return on assets is 9.30%. Ansys, Inc. (NASDAQ:ANSS) quarterly performance is -9.15%.

Leave a Reply

Your email address will not be published. Required fields are marked *